share_log

Larimar Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Deerfield Management Company, L.P.(34.82%),James E. Flynn(34.82%), etc.

Larimar Therapeutics | SC 13D/A:超过5%持股股东披露文件(修正)-Deerfield Management Company, L.P.(34.82%),James E. Flynn(34.82%)等

美股sec公告 ·  02/16 14:17
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息